Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PicosTech is a South Korean biotechnology company specializing in advanced transdermal drug delivery systems (TDDS), with a primary focus on dissolving microneedle (DMN) technology. The company develops and manufactures innovative microneedle patches for both cosmeceutical and pharmaceutical applications, enabling the effective delivery of active ingredients through the skin barrier. Their expertise spans from R&D to mass production, offering CDMO services for partners looking to utilize microneedle platforms. PicosTech's product portfolio includes anti-aging treatments, hair growth solutions, and localized pain relief applications. By leveraging their proprietary manufacturing processes, they aim to replace traditional needle injections with painless, self-administered patch-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PICOSTECH.